Related content

DNA vaccination with the immunodominant tachyzoite surface antigen (SAG-1) protects against adult acquired Toxoplasma gondii infection but does not prevent maternofoetal transmission

By Couper K.N.   Nielsen H.V.   Petersen E.   Roberts F.   Roberts C.W.   Alexander J.  

Vaccine, Vol. 21, Iss. 21, 2003-06 ,pp. : 2813-2820

Elsevier

Access to resources Recommend Favorite

Immunogenicity of recombinant BCG producing the GRA1 antigen from Toxoplasma gondii

By Supply P.   Sutton P.   Coughlan S.N.   Bilo K.   Saman E.   Trees A.J.   Cesbron Delauw M.-F.   Locht C.  

Vaccine, Vol. 17, Iss. 7, 1999-02 ,pp. : 705-714

Elsevier

Access to resources Recommend Favorite

Noticeable Effect of Juniperus Procera as Toxoplasma Gondii Tachyzoites Inhibitor in Vivo

By  

The International Journal of Health, Wellness, and Society, Vol. 1, Iss. 2, 2011-01 ,pp. : 197-204

Common Ground Publishing

Access to resources Recommend Favorite

The urban house mouse (Mus domesticus) as a reservoir of infection for the human parasite Toxoplasma gondii: an unrecognised public health issue?

By Murphy R. Gai   Williams R. Huw   Hughes Jacqueline   Hide Geoff   Ford Norma   Oldbury David  

International Journal of Environmental Health Research, Vol. 18, Iss. 3, 2008-06 ,pp. : 177-185

Taylor & Francis Ltd

Access to resources Recommend Favorite

Toxoplasma gondii levels in swine operations: differences due to technology choice and impact on costs of production

By Wang C.-H.   Diderrich V.   Kliebenstein J.   Patton S.   Zimmerman J.   Hallam A.   Bush E.   Faulkner C.   McCord R.  

Food Control, Vol. 13, Iss. 2, 2002-03 ,pp. : 103-106

Elsevier

Access to resources Recommend Favorite